Rendering of what the future Sanford Medical Center Fargo campus will look like with future growth.
This clinical trial offers hope for millions living with partial rotator cuff tear issues, one of the most common orthopedic impairments in the US and other developed countries. Note that Sanford Health is a contributing partner at World Stem Cell Summit, Jan .22-25, Miami.
By Kevin Wallevand Forum News Service
FARGO, N.D. — After a year-long study, the Food and Drug Administration has approved the safety of an ongoing stem cell treatment project that Sanford Health in Fargo, N.D., and Sioux Falls are leading.
It’s a medical advance that could eventually change the lives of millions living with partial rotator cuff tear issues, a condition affecting muscles and tendons surrounding the shoulder joint. The treatment’s developers say it’s one of the most common orthopedic impairments in the United States and other developed countries.
After passing the safety trial phase in December 2018, more patients from the Dakotas will be added to the next phase of the study, which if passed will grant FDA approval to market the treatment.
The treatment uses liposuction to remove fat tissue from the belly, treats it with a special enzyme and then isolates stem cells from the fat. These stem cells are called adipose-derived regenerative cells.
Link to Full News Article
/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
